Peer-led prevention: can gancheros help stop HIV, hepatitis c, and overdose in NYC?
NCT ID NCT06316739
First seen Jul 24, 2026 · Last updated Jul 24, 2026
Summary
This pilot trial tests whether training Gancheros—people who provide injection services in exchange for money or drugs—can lower HIV, hepatitis C, and overdose risks among migrant Puerto Rican people who inject drugs in New York City. Gancheros will attend six sessions on prevention and then share supplies like sterile syringes and naloxone with their clients over four months. The study will assess whether clients use sterile syringes and carry naloxone more often.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- a behavioral intervention training Gancheros in HIV, HCV, and overdose prevention outreach
- What this could lead to
- If successful, this approach could offer a community-driven way to reduce HIV, hepatitis C, and overdose risks among a hard-to-reach population.
- What could go wrong
- This is a small pilot study with only 10 Gancheros and 60 clients, so results may not apply broadly. The intervention depends on Gancheros' willingness and ability to share prevention messages and supplies.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HCV are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
CUNY Graduate School of Public Health & Health Policy
New York, New York, 10027, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Small cash rewards may keep HIV-positive mothers in treatment — a trial puts the idea to the test
- Long-acting HIV shot studied in patients with severe kidney problems
- Can two hours of mindfulness ease chronic pain in HIV patients?
- Can a clinic-and-social-media campaign boost HIV prevention among black women?
- Choice of Long-Acting HIV prevention could transform care for young people in rural south africa
- Could meditation and a simple device ease HIV nerve pain?